| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
63,610,000 |
| Market
Cap: |
322.50(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.6 - $8.07 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile MeiraGTx Holdings is a clinical stage gene therapy company with six programs in clinical development and a pipeline of preclinical and research programs. Co.'s focus is on three areas of unmet medical need: ocular, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases and severe forms of xerostomia. Co.'s product candidates include: AAV-RPE65 for the treatment of retinal dystrophy associated with mutations in the RPE65 gene; AAV-CNGB3 and AAV-CNGA3 for the treatment of Achromatopsia; AAV-AIPL1 for the treatment of Leber congenital amaurosis 4; as well as AAV-RDH12 for the treatment of RDH12 Mutation-Associated Retinal Dystrophy.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
4,353,826 |
| Total Buy Value |
$0 |
$0 |
$0 |
$25,047,440 |
| Total People Bought |
0 |
0 |
0 |
3 |
| Total Buy Transactions |
0 |
0 |
0 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Marcus Joel S |
Director |
– • – |
2020-08-12 |
4 |
S |
$14.15 |
$112,620 |
D/D |
(7,959) |
0 |
|
-15% |
|
| Marcus Joel S |
Director |
– • – |
2020-08-11 |
4 |
S |
$13.86 |
$103,950 |
D/D |
(7,500) |
7,959 |
|
-22% |
|
| Marcus Joel S |
Director |
– • – |
2020-08-10 |
4 |
OE |
$5.63 |
$87,034 |
D/D |
15,459 |
15,459 |
|
- |
|
| Giroux Richard |
CFO & COO |
• – – |
2020-08-03 |
4 |
GD |
$0.00 |
$0 |
D/D |
200,000 |
864,518 |
|
- |
|
| Naylor Stuart |
Chief Development Officer |
• – – |
2020-07-21 |
4 |
AS |
$15.04 |
$115,778 |
D/D |
(7,698) |
463,963 |
|
-7% |
|
| Shenk Thomas E |
Director |
– • – |
2020-07-20 |
4 |
AS |
$15.00 |
$100,005 |
I/I |
(6,667) |
157,476 |
|
-5% |
|
| Naylor Stuart |
Chief Development Officer |
• – – |
2020-07-20 |
4 |
AS |
$15.00 |
$35,340 |
D/D |
(2,356) |
471,661 |
|
-5% |
|
| Forbes Alexandria |
President and CEO |
• • – |
2020-06-29 |
4 |
GD |
$0.00 |
$0 |
D/D |
2,300 |
1,415,781 |
|
- |
|
| Forbes Alexandria |
President & CEO |
• • – |
2020-05-22 |
4 |
AS |
$15.18 |
$138,518 |
D/D |
(9,125) |
1,418,081 |
|
-7% |
|
| Forbes Alexandria |
President & CEO |
• • – |
2020-05-21 |
4 |
AS |
$15.18 |
$223,632 |
D/D |
(14,732) |
1,427,206 |
|
-11% |
|
| Giroux Richard |
CFO & COO |
• – – |
2020-05-21 |
4 |
AS |
$15.16 |
$178,676 |
D/D |
(11,786) |
1,064,518 |
|
-11% |
|
| Forbes Alexandria |
President & CEO |
• • – |
2020-05-20 |
4 |
AS |
$15.04 |
$92,391 |
D/D |
(6,143) |
1,441,938 |
|
-9% |
|
| Giroux Richard |
CFO & COO |
• – – |
2020-05-20 |
4 |
AS |
$15.03 |
$92,329 |
D/D |
(6,143) |
1,076,304 |
|
-9% |
|
| Giroux Richard |
CFO & COO |
• – – |
2020-05-13 |
4 |
AS |
$15.38 |
$1,092 |
D/D |
(71) |
1,082,447 |
|
-16% |
|
| Marcus Joel S |
Director |
– • – |
2020-05-12 |
4 |
S |
$15.77 |
$77,621 |
I/I |
(4,922) |
75,000 |
|
19% |
|
| Shenk Thomas E |
Director |
– • – |
2020-05-11 |
4 |
AS |
$15.00 |
$32,760 |
I/I |
(2,184) |
164,143 |
|
-19% |
|
| Naylor Stuart |
Chief Development Officer |
• – – |
2020-05-11 |
4 |
AS |
$15.39 |
$173,969 |
D/D |
(11,304) |
474,017 |
|
-19% |
|
| Giroux Richard |
CFO & COO |
• – – |
2020-04-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
350 |
1,167,518 |
|
- |
|
| Shenk Thomas E |
Director |
– • – |
2020-04-20 |
4 |
AS |
$15.00 |
$67,230 |
I/I |
(4,482) |
166,327 |
|
-5% |
|
| Naylor Stuart |
Chief Development Officer |
• – – |
2020-04-20 |
4 |
AS |
$15.00 |
$10,440 |
D/D |
(696) |
485,321 |
|
-5% |
|
| Naylor Stuart |
Chief Development Officer |
• – – |
2020-02-19 |
4 |
AS |
$17.60 |
$105,600 |
D/D |
(6,000) |
486,017 |
|
-30% |
|
| Naylor Stuart |
Chief Development Officer |
• – – |
2020-02-18 |
4 |
AS |
$18.30 |
$109,912 |
D/D |
(6,000) |
492,017 |
|
-31% |
|
| Forbes Alexandria |
President & CEO |
• • – |
2020-01-29 |
4 |
AS |
$17.77 |
$266,550 |
D/D |
(15,000) |
1,448,081 |
|
-14% |
|
| Forbes Alexandria |
President & CEO |
• • – |
2020-01-28 |
4 |
AS |
$17.35 |
$260,328 |
D/D |
(15,000) |
1,463,081 |
|
-10% |
|
| Forbes Alexandria |
President & CEO |
• • – |
2019-12-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
1,478,081 |
|
- |
|
130 Records found
|
|
Page 5 of 6 |
|
|
0.03 (0.59%) 
